Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

0.0%

0 terminated/withdrawn out of 5 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

20%

1 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
4(80.0%)
Phase 4
1(20.0%)
5Total
N/A(4)
Phase 4(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (5)

Showing 5 of 5 trials
NCT05348148Not ApplicableRecruiting

Comparison of the Effects for Lightening the Shiners Among Different Treatments for Rhinitis

Role: lead

NCT04077918Not ApplicableUnknown

Comparison of the Effects of Different Protein Diet in Hemodialysis Patients

Role: lead

NCT04070690Not ApplicableUnknown

The Influences of Dialysate Bicarbonate Concentrations on Hemodialysis Patients

Role: lead

NCT04071028Not ApplicableCompleted

Heart Rate Variability as an Indicator Associated With the Improvement of Dysmenorrhea After the Warm-water Footbath

Role: lead

NCT01845090Phase 4Unknown

The Effect of Lanthanum Carbonate on Fibroblast Growth Factor 23

Role: lead

All 5 trials loaded